Developing resources and animal models for studying high-threat biological agents.
Resources, Workforce Development, and Animal Models for the Rutgers RBL
This study is all about making a special lab at Rutgers University even better at researching serious germs like the ones that cause COVID-19 and tuberculosis, so we can find new ways to treat and diagnose these diseases, which could help patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10910194 on NIH RePORTER |
What this research studies
This research focuses on enhancing the capabilities of the Rutgers University Regional Biocontainment Laboratory (RBL) to conduct advanced research on dangerous pathogens, including SARS-CoV-2 and Mycobacterium tuberculosis. The project aims to improve laboratory facilities and support services, establish best practices for working with high-containment pathogens, and develop animal models to better understand these diseases. By collaborating with academic and commercial partners, the RBL seeks to strengthen pandemic preparedness and biothreat response efforts. Patients may benefit indirectly through advancements in treatments and diagnostics for infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals affected by or at risk for infections caused by high-threat pathogens like SARS-CoV-2 and tuberculosis.
Not a fit: Patients with non-infectious diseases or those not affected by the targeted pathogens may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive measures for serious infectious diseases affecting patients.
How similar studies have performed: Previous research on similar high-threat pathogens has shown promise in improving treatment and understanding of infectious diseases, indicating that this approach is grounded in established scientific methods.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Alland, David — Rutgers Biomedical and Health Sciences
- Study coordinator: Alland, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.